| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68f2bd3d611c7a2a832128d8430d9193 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-18 |
| filingDate |
2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_356adf67832afa9022a5572bfd067580
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_668052310e4b4bd1bbe7106f2ace70b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ec7f97aca86b406f7e21530c8071cad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_861dd0c3205e7f5548217faa5a57d13e |
| publicationDate |
2011-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2010011532-A |
| titleOfInvention |
CIDEA MODULATORS IN THE TREATMENT OF ACNE, SEBORREIC DERMATITIS OR HYPERSEBORREA. |
| abstract |
The invention relates to an in vitro or in vivo method for selecting the candidate compounds for the preventive or curative treatment of acne, seborrheic dermatitis or cutaneous disorders associated with hyperseborrhea, which comprises determining the ability of a compound to modulate the expression or activity of the CIDEA protein, and also the use of the modulators of the expression or activity of this protein, for the treatment of acne, seborrheic dermatitis or skin disorders associated with hyperseborrhea. The invention also relates to methods for in vitro diagnosis or in vitro prognosis for these pathologies. |
| priorityDate |
2008-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |